What is Biogenera worth?
$87.9Mlast known valuation
Free account
See the evidence behind this price
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Biogenera
- ·The full record, as it builds
Create free account
No card required
Funding history
No rounds on record
No funding rounds for Biogenera are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Pro members can request priority coverage with a 48-hour turnaround.
How Biogenera's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Biogenera, we compose those signals into the PA Mark — a weighted composite of 2 recent pricing inputs, decayed by age and reset on new rounds. The implied valuation multiplies the mark by shares outstanding. Full methodology →
Frequently asked
- What is Biogenera worth?
- Biogenera's implied valuation is $87.9M, based on the PA Mark composite price of about $216 per share as of Sep 2026.
- How much has Biogenera raised?
- Biogenera has raised $15.1M in total funding across its recorded rounds.